AIP
TMO icon

Arrowpoint Investment Partners’s Thermo Fisher Scientific TMO Stock Holding History

Arrowpoint Investment Partners’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-200
Closed -$104K – 1231
2024
Q4 		$104K Buy
+200
New +$110K 0.02% 579

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Arrowpoint Investment Partners's TMO Position: Q1 2026 in Review

Arrowpoint Investment Partners sold out of Thermo Fisher Scientific (TMO) in Q1 2026, closing a stake of 1,290 shares — an estimated $747K sold.

Arrowpoint Investment Partners first reported a position in TMO in Q4 2024 and held it in 3 quarters. The position peaked at $747K in Q4 2025. 2,595 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Arrowpoint Investment Partners reported no remaining Thermo Fisher Scientific position as of Q1 2026 after selling out during the quarter.
  • Arrowpoint Investment Partners sold 1,290 Thermo Fisher Scientific shares in Q1 2026, an estimated $747K.
  • Arrowpoint Investment Partners first reported a position in Thermo Fisher Scientific in Q4 2024 and held it in 3 quarters.
  • Arrowpoint Investment Partners's Thermo Fisher Scientific position peaked at $747K in Q4 2025.
  • 2,595 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Arrowpoint Investment Partners's 13F filing for Q1 2026, filed 14 May 2026.